Moreover, the relationship between the upregulation of KCNQ1OT1 and poor prognosis of CRC patients also suggested that higher KCNQ1OT1 levels in patients make them resistant to chemotherapy or other anti-cancer treatments (Li Y. et al., 2019). Here, KCNQ1OT1 is linked to cancer.